cific inducible gene expression in the mouse central nervous system. Max demonstrated that direct accumulation of ⌬FosB in reward pathways, including the nucleus accumbens, caused a predilection to cocaine addiction. 7 Subsequent studies also confirmed that accumulation of ⌬FosB in these reward circuits predisposed to opiate and nicotine addiction as well. 8 Max's Ph.D. work won the prize for "Best Thesis" in his graduating class at Yale.
Max initially anticipated a clinician scientist's career in psychiatry or neurology. However, the exposure to the field of anesthesiology as a medical student at Yale highlighted by the exquisite teaching of Keith Ruskin, M. As a resident at Penn, Max encountered an otherwise healthy patient with narcolepsy and cataplexy who took more than 7 h to emerge from a standard inhaled general anesthetic. This case sparked Max's interest in the regulation of arousal state control and the actions of anesthetic drugs on endogenous neuronal circuits. Because the underlying genetic basis of narcolepsy with cataplexy had just been discovered to be impaired signaling in the wake promoting and sustaining hypocretin/orexin system, 10 -12 and because there are only a few thousand hypocretin/orexin neurons all confined to the hypothalamus, Max pursued the hypothesis that inhaled anesthetics should inhibit the activity of hypocretin/ orexin neurons, their excitatory afferents, or their efferents, leading to delayed anesthetic emergence. Medical Sciences to pursue the interactions of anesthetics with the hypocretin/orexin system. He built custom highthroughput models to accelerate anesthetic phenotyping of genetically engineered mice behaviorally 13, 14 and electroencephalographically. 15 Using a mouse model system of narcolepsy and cataplexy in collaboration with the Yanagisawa laboratory, Max demonstrated that isoflurane and sevoflurane do indeed inhibit hypocretin/orexin neurons but do not affect activity in neighboring neurons. Moreover, this work demonstrated that narcoleptic mice also exhibited delayed emergence from the halogenated ether anesthetics. 16 These findings encouraged Max to follow the overreaching hypothesis that the hypnotic component of general anesthesia arises when anesthetic drugs hijack endogenous sleep-wake circuits. 17, 18 However, just as decades of research have highlighted the stunning complexity in potential molecular targets of anesthetic action, studies by Max and others are beginning to highlight the diversity of distinct anesthetic agents upon specific neuronal targets, including the hypocretin/orexin system. 19, 20 Building upon the orexin/hypocretin work, Max has hypothesized that the forward and reverse processes through which the state of anesthesia arises and dissipates need not be identical. He has convincingly shown that hysteresis for anesthesia induction and emergence exists in multiple species and cannot be explained purely by pharmacokinetics. He has termed this barrier to arousal-state change as "neural inertia," and it has many implications to clinical practice as well as to the fundamental neurobiology of consciousness. His questions have taken him from the hyperbaric chamber to Drosophila, bringing new collaborations back to anesthesiology and reinvigorating the intellectual curiosity and the scientific credibility of our discipline. Max was recently awarded a National Institute of General Medical Sciences R01, which continues to focus upon the interface between natural sleep and anesthesia. This grant will use electrophysiology in combination with classic and novel techniques to identify critical neuroanatomic substrates underlying volatile anesthetic hypnosis. Sheryl Beck, Ph.D. (Department of Anesthesiology and Critical Care, Penn Medicine, Philadelphia, Pennsylvania), has become an indispensable collaborator on these studies.
Max is also a great mentor, as evidenced by the numerous medical students and residents who have chosen to work with him. A Penn fourth-year medical student won "Best Thesis" Prize for his work on dexmedetomidine in Max's laboratory in [2007] [2008] . Several residents have gone on to win awards at the Pennsylvania Anesthesia Resident Conference. He also has the unique distinction of being the advisor for a neuroscience M.D./Ph.D. student who won the top research cash prize at the Sleep Retreat this year for his work. For someone at this stage of Max's career, this was a unique honor, and this student will hopefully be a future anesthesiologist/scientist based upon his interactions with Max.
In addition to his clinical acumen and his fundamental research, Max also excels at teaching. He is a sought-after lecturer in the University at large, in addition to his bedside teaching of the residents.
Max Kelz is a great example of a young physician-scientist/anesthesiologist and is a true triple threat. On top of that, he is one of the most collegial and friendly individuals and is always there to help a colleague, whether it be clinical, academic, or personal issues.
